BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Upadhyay VA, Geisler BP, Sun L, Uhl L, Kaufman RM, Stowell C, Makar RS, Bendapudi PK. Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative. Br J Haematol 2019;186:490-8. [PMID: 31131442 DOI: 10.1111/bjh.15932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zheng XL. The standard of care for immune thrombotic thrombocytopenic purpura today. J Thromb Haemost 2021;19:1864-71. [PMID: 34060225 DOI: 10.1111/jth.15406] [Reference Citation Analysis]
2 Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, Russell L, Tarawneh R, Valdes J, Peyvandi F. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost 2020;18:2486-95. [PMID: 32914582 DOI: 10.1111/jth.15006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
3 Moosavi H, Ma Y, Miller MJ, Duncan A. Validation of PLASMIC score: an academic medical center case series (2012-present). Transfusion 2020;60:1536-43. [PMID: 32588918 DOI: 10.1111/trf.15916] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Udayasankar M, Rammohan A, Sathya AC, Rajakumar A, Rela M. Thrombotic Thrombocytopenic Purpura After Live Liver Donation: Villain or Scapegoat? Cureus 2021;13:e12890. [PMID: 33654582 DOI: 10.7759/cureus.12890] [Reference Citation Analysis]
5 Kim CH, Simmons SC, Wattar SF, Azad A, Pham HP. Potential impact of a delayed ADAMTS13 result in the treatment of thrombotic microangiopathy: an economic analysis. Vox Sang 2020;115:433-42. [PMID: 32227485 DOI: 10.1111/vox.12912] [Reference Citation Analysis]
6 Elessa D, Talbot A, Lombion N, Harel S, Galicier L, Veyradier A, Joly B, Andreoli A, Rigaudeau S, Azoulay É, Coppo P, Royer B, Arnulf B. Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature. Br J Haematol 2019;188:338-40. [DOI: 10.1111/bjh.16333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
7 Lancelot M, Miller MJ, Roback J, Stowell SR. Refractory thrombotic thrombocytopenic purpura related to checkpoint inhibitor immunotherapy. Transfusion 2021;61:322-8. [PMID: 33119913 DOI: 10.1111/trf.16117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]